Paroxysmal Atrial Fibrillation in Horses: Pathophysiology, Diagnostics and Clinical Aspects.

Animals (Basel). March 2022;12(6):.

Sofie Troest Kjeldsen¹, Sarah Dalgas Nissen², Rikke Buhl³, Charlotte Hopster-Iversen⁴

¹ Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Agrovej 8, DK-2630 Taastrup, Denmark.; ² Laboratory of Cardiac Physiology, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.; ³ Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Agrovej 8, DK-2630 Taastrup, Denmark.; ⁴ Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Agrovej 8, DK-2630 Taastrup, Denmark.

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in horses causing poor performance. As in humans, the condition can be intermittent in nature, known as paroxysmal atrial fibrillation (pAF). This review covers the literature relating to pAF in horses and includes references to the human literature to compare pathophysiology, clinical presentation, diagnostic tools and treatment. The arrhythmia is diagnosed by auscultation and electrocardiography (ECG), and clinical signs can vary from sudden loss of racing performance to reduced fitness or no signs at all. If left untreated, pAF may promote electrical, functional and structural remodeling of the myocardium, thus creating a substrate that is able to maintain the arrhythmia, which over time may progress into permanent AF. Long-term ECG monitoring is essential for diagnosing the condition and fully understanding the duration and frequency of pAF episodes. The potential to adapt human cardiac monitoring systems and computational ECG analysis is therefore of interest and may benefit future diagnostic tools in equine medicine.

Keywords

arrhythmia; electrocardiogram; equine cardiology; implantable loop recorder; long-term monitoring device; paroxysmal atrial fibrillation; poor performance;

Article Tools:

Medline

Email to me

Archives Highlights:

Canine hypothyroidism: avoiding over diagnosing the condition
The clinical signs of hypothyroidism are vague and non-specific, as are the routine haematological and biochemical changes. When assessing the thyroid axis, the classical finding of decreased total thyroxine and increased thyroid-stimulating hormone is highly specific for the diagnosis of hypothyroidism, but has less good sensitivity.

Upper and lower respiratory airway complaints among female veterinary staff.
Atopy was seen in 31% of the 109 female participants. Symptoms of rhinoconjunctivitis were the most frequent complaints (n = 92; 84%). Symptoms of upper and lower airways were highly correlated and an asthma diagnosis was confirmed in 11% of participants. Modelling revealed that sensitization against cats/dogs was a significant risk factor for respiratory symptoms of upper [odds ratio (OR) 4.61] and lower airways (OR 5.14), physician-confirmed rhinoconjunctivitis (OR 13.43), and asthma (OR 9.02) in assistant staff of small-animal practices.

Insulins for the long term management of diabetes mellitus in dogs: a review.
The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.

Survey of self-reported radiation safety practices among North American veterinary technicians involved in equine radiography using portable x-ray equipment.
Lead apron use was suboptimal, reported as "always" for 80.0% (104/130) of tube operators and 83.1% (123/148) of cassette holders. Approximately 20% of participants never wore thyroid shields, and approximately 90% never wore lead eyeglasses. Almost 50% of participants did not have lead eyeglasses available. Although > 55% of participants always held the x-ray equipment by hand, 58.4% (73/125) of tube operators and 25.0% (35/140) of cassette holders never wore gloves.

Effect of Clostridium butyricum on Gastrointestinal Infections.
Owing to its preventive and ameliorative effects on gastrointestinal infections, C. butyricum MIYAIRI 588 (CBM 588) has been used as a probiotic in clinical and veterinary medicine for decades. C. butyricum is widely effective against Clostoridioides difficile, the causative pathogen of nosocomial infections; Helicobacter pylori, the causative pathogen of gastric cancer; and antibiotic-resistant Escherichia coli. C. butyricum is expected to be one of the antimicrobial-resistance (AMR) countermeasures for the One-health approach.